A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
| Status: | Completed |
|---|---|
| Conditions: | Cosmetic |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 25 - 70 |
| Updated: | 4/21/2016 |
| Start Date: | November 2012 |
| End Date: | August 2013 |
An Eight-Week, Multi-Site, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Trial to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Subjects With Rosacea Followed by an Open-Label Extension
This is a multi-site, four-visit, eight-week, double-blind, randomized, vehicle-controlled,
parallel-group study followed by an eight-week open-label extension to evaluate the safety,
tolerability, and potential effects of Anatabloc Facial Cream. The secondary aim is to
evaluate if Anatabloc Facial Cream improves the appearance of the skin in subjects with mild
to moderate rosacea.
parallel-group study followed by an eight-week open-label extension to evaluate the safety,
tolerability, and potential effects of Anatabloc Facial Cream. The secondary aim is to
evaluate if Anatabloc Facial Cream improves the appearance of the skin in subjects with mild
to moderate rosacea.
Inclusion Criteria:
- age between 25-70 years
- diagnosed with mild to moderate rosacea
Exclusion Criteria:
- allergy or sensitivity to the study products or their components
- severe rosacea
- current use of glucocorticoids, anti-acne products, antibiotics, topical retinoids,
or vasoactive drugs
- recent oral isotretinoin use
- current use of anatabine-containing supplements (ie. Anatabloc, Anatabloc Unflavored,
CigRx)
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials